Impact of HMGB1, RAGE, and TLR4 in Alzheimer's disease (AD): from risk factors to therapeutic targeting

YN Paudel, E Angelopoulou, C Piperi, I Othman… - Cells, 2020 - mdpi.com
Alzheimer's disease (AD) is a devastating neurodegenerative disorder and a leading cause
of dementia, with accumulation of amyloid-beta (Aβ) and neurofibrillary tangles (NFTs) as …

Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside

A Mishra, R Bandopadhyay, PK Singh, PS Mishra… - Metabolic Brain …, 2021 - Springer
Neuroinflammation is one of the host defensive mechanisms through which the nervous
system protects itself from pathogenic and or infectious insults. Moreover, neuroinflammation …

High mobility group box-1 and blood–brain barrier disruption

M Nishibori, D Wang, D Ousaka, H Wake - Cells, 2020 - mdpi.com
Increasing evidence suggests that inflammatory responses are involved in the progression
of brain injuries induced by a diverse range of insults, including ischemia, hemorrhage …

HMGB1-mediated neuroinflammatory responses in brain injuries: potential mechanisms and therapeutic opportunities

YN Paudel, E Angelopoulou, C Piperi, I Othman… - International Journal of …, 2020 - mdpi.com
Brain injuries are devastating conditions, representing a global cause of mortality and
morbidity, with no effective treatment to date. Increased evidence supports the role of …

Neuro-inflammation modulation and post-traumatic brain injury lesions: from bench to bed-side

A Jacquens, EJ Needham, ER Zanier, V Degos… - International journal of …, 2022 - mdpi.com
Head trauma is the most common cause of disability in young adults. Known as a silent
epidemic, it can cause a mosaic of symptoms, whether neurological (sensory–motor …

Post-traumatic epilepsy and comorbidities: advanced models, molecular mechanisms, biomarkers, and novel therapeutic interventions

VM Golub, DS Reddy - Pharmacological reviews, 2022 - ASPET
Post-traumatic epilepsy (PTE) is one of the most devastating long-term, network
consequences of traumatic brain injury (TBI). There is currently no approved treatment that …

Neuroinflammation in post-traumatic epilepsy: pathophysiology and tractable therapeutic targets

R Sharma, WL Leung, A Zamani, TJ O'brien… - Brain sciences, 2019 - mdpi.com
Epilepsy is a common chronic consequence of traumatic brain injury (TBI), contributing to
increased morbidity and mortality for survivors. As post-traumatic epilepsy (PTE) is drug …

Potential neuroprotective effect of the HMGB1 inhibitor glycyrrhizin in neurological disorders

YN Paudel, E Angelopoulou, B Semple… - ACS chemical …, 2020 - ACS Publications
Glycyrrhizin (glycyrrhizic acid), a bioactive triterpenoid saponin constituent of Glycyrrhiza
glabra, is a traditional medicine possessing a plethora of pharmacological anti-inflammatory …

HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury

SW Tan, Y Zhao, P Li, YL Ning, ZZ Huang… - Journal of …, 2021 - Springer
Background Cognitive impairment in the late stage of traumatic brain injury (TBI) is
associated with the NOD-, LRR and pyrin domain-containing protein 3 (NLRP3) …

HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target

D Mao, Y Zheng, F Xu, X Han, H Zhao - Frontiers in Neurology, 2022 - frontiersin.org
High-mobility group box-1 (HMGB1) is a nuclear protein associated with early inflammatory
changes upon extracellular secretion expressed in various cells, including neurons and …